bpc 157 fda warning not approved safety bpc-157 peptide Would you inject an unregulated substance if it promised An FDA Committee Just Voted

P-glycoprotein function at the blood-brain barrier: effects of age and gender

Matching Peptide Characteristics to Application Needs Companies working on making the next wave of medicines to treat obesity may choose GLP-1 peptide Cagrilintide because it has a new way of working and could be used with other medicines, which could help them stand out in the crowded GLP-1 market

In rats, sCT induces weight loss as in humans or other animal models while in mice, weight gain is observed

Dabigatran has been examined as a fixed dose for stroke prevention in AFib, but the FDA has approved the adjusted dose of 75 mg twice daily in patients with CrCl 15-30 mL/min

In an April post on X, Kennedy wrote that for each peptide, the committee will weigh the full clinical, pharmacological, and safety evidence. The next day, he asserted that these peptides are like supplements, and therefore might not need to go through clinical trials